Clinical Policy Title: Molecular targeted therapy
ثبت نشده
چکیده
CP# 02.01.08 Familial polyposis gene testing CP# 02.01.14 Gene expression profile testing for breast cancer CP# 11.04.02 Genetic testing for autism spectrum disorders CP# 02.01.02 Genetic testing for breast and ovarian cancer CP# 02.01.07 Genetic testing for cystic fibrosis CP# 00.01.03 Genetic testing for cytochrome p450 Polymorphisms (CYP2C19) CP# 05.01.03 Genetic testing for G1691A Polymorphisms Factor V Leiden CP# 04.01.02 Genetic testing for Long QT syndrome (LQTS) CP# 02.01.04 Genetic testing for primary autosomal recessive microcephaly CP# 02.01.09 Genetic testing for rare diseases CP# 13.01.01 Genetic testing for prostate cancer prognosis CP# 09.01.09 Genetic testing in neurology CP# 02.01.18 Genetic testing in sensorineural hearing loss
منابع مشابه
Resistance to HER2-targeted therapy
Production and approval of trastuzumab (Herceptin®) for the treatment of metastatic breast cancer (MBC) was a millstone in antibody-based targeted therapy in the cancer treatment. However, despite the early success in the clinical trials, trastuzumab failed to appreciate the initial attraction due to development of resistance to the drug. The majority of patients who benefit from the drug...
متن کاملSystemic Targeted Alpha Radiotherapy for Cancer
Background: The fundamental principles of internal targeted alpha therapy for cancer were established many decades ago.The high linear energy transfer (LET) of alpha radiation to the targeted cancer cellscauses double strand breaks in DNA. At the same time, the short range radiation spares adjacent normal tissues. This targeted approach complements conventional external beam radiotherapy and ch...
متن کاملClinical Policy Title: Genetic testing for cytochrome P450 polymorphisms
CP# 02.01.08 Familial polyposis gene testing CP# 02.01.14 Gene expression profile testing for breast cancer CP# 11.04.02 Genetic testing for autism spectrum disorders CP# 02.01.02 Genetic testing for breast and ovarian cancer CP# 02.01.07 Genetic testing for cystic fibrosis CP# 05.01.03 Genetic testing for G1691A polymorphisms Factor V Leiden CP# 04.01.02 Genetic testing for Long QT syndrome (L...
متن کاملClinical Policy Title: Genetic tests for Duchenne muscular dystrophy
CP# 02.01.01 Maternal genetic testing CP# 02.01.02 Genetic testing for breast and ovarian cancer CP# 02.01.03 Array comparative genomic hybridization testing CP# 02.01.13 Pharmacogenetic testing for warfarin CP# 02.01.07 Genetic testing for cystic fibrosis CP# 02.01.08 Familial polyposis gene testing CP# 02.01.10 COLARIS® test for Lynch syndrome CP# 02.01.11 AfirmaTM gene expression classifier ...
متن کاملProduction and Evaluation of Specific Single-Chain Antibodies against CTLA-4 for Cancer-Targeted Therapy
Background: Cytotoxic T lymphocyte–associated antigen 4 (CTLA-4) molecules are expressed on T-cells and inhibit their function by inhibiting activation of subsequent T-cell molecular pathways. Blocking of CTLA-4 inhibits the growth of malignant tumor cells. Anti-CTLA-4 monoclonal antibodies activate the immune system against cancer. Due to several advantages of single-chain antibodi...
متن کاملEfficacy of insulin targeted gene therapy for type 1 diabetes mellitus: A systematic review and meta-analysis of rodent studies
Objective(s): Diabetes mellitus (DM) is a major worldwide public health challenge, for which gene therapy offers a potential therapeutic approach. To date, no systematic review or meta-analysis has been published in this area, so we examined all relevant published studies on rodents to elucidate the overall effects of gene therapy on bodyweight, intraperitoneal glucose...
متن کامل